🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Triple-negative breast cancer (TNBC) is among the most aggressive and letha...
Status
Recruiting
Location
Fondazione IRCCS San Gerardo Dei Tintori
Start Date
2025-03-06
Trial ID
NCT06690840
Treatments Being Tested
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
This is a single-center, open-label clinical study of anti-HER2-CAR-T cells...
Status
Recruiting
Location
Phase I Clinical Trials Center Of The First Hospital of China Medical University
Start Date
2024-01-16
Trial ID
NCT06101082
Treatments Being Tested
This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-07-31
Trial ID
NCT05987696
Treatments Being Tested
Background: * Malignant mesothelioma is a form of cancer that develops on ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-05-11
Trial ID
NCT01362790
Treatments Being Tested